Consensus statement on the exploration of clinical translation and application of electron ultra-high dose rate FLASH radiotherapy

Abstract

Ultra-high dose rate FLASH Radiotherapy (FLASH-RT) has attracted wide attention because the well-known FLASH effect and the extremely short irradiation time. During FLASH-RT, high radiation doses and dose rate (usually thousands of times compared with conventional radiotherapy (CONV-RT)) are delivered to the tumor area. This novel irradiation technique shows a reduction of normal tissue injury (20-40%) in comparison to CONV-RT. Meanwhile, FLASH-RT maintaining comparable tumor killing effect as CONV-RT. With the progress of basic research on FLASH-RT in reducing radiation-induced injury to normal tissues, clinical trials of FLASH-RT have been carried out across the world. To date, there is no consensus in China focused on the exploration of clinical transformation and application of electron FLASH-RT. Therefore, the China Anti-Cancer Association Radiation Oncology Committee and the Chinese Medical Doctor Association Radiation Oncology Physician Committee gathered a group of experts together to develop this consensus statement. The authors discuss their current views on electron FLASH-RT, demonstrate the unresolved questions, provide insights for the further application of this technology in clinical practice.

Keywords

clinical application / Consensus statement / electron FLASH radiotherapy / transformation

References

[1] Abdel-Wahab M, Giammarile F, Carrara M et al. Radiotherapy and theranostics: a Lancet Oncology Commission. The Lancet Oncology. 2024; 25(11): e545-e580.

[2] Jaffray DA, Knaul F, Baumann M, Gospodarowicz M. Harnessing progress in radiotherapy for global cancer control. Nature Cancer. 2023; 4(9): 1228-1238.

[3] Lowe D, Roy L, Tabocchini MA et al. Radiation dose rate effects: what is new and what is needed? Radiation and environmental biophysics. 2022; 61(4): 507-543.

[4] Petersson K. FLASH radiotherapy: What, how and why? Research Outreach: the Outreach Quarterly Connecting Science With Society. 2020; 2020(117): 66-69.

[5] Vozenin MC, Bourhis J, Durante M. Towards clinical translation of FLASH radiotherapy. Nat Rev Clin Oncol. 2022; 19(12): 791-803.

[6] Hughes JR, Parsons JL. FLASH Radiotherapy: Current Knowledge and Future Insights Using Proton-Beam Therapy. Int J Mol Sci. 2020; 21(18).

[7] Wang X, Luo H, Zheng X, Ge H. FLASH radiotherapy: research process from basic experimentation to clinical application. Prec Radiat Oncol. 5: 259.

[8] Mascia AE, Daugherty EC, Zhang Y et al. Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases: The FAST-01 Nonrandomized Trial. JAMA Oncol. 2023; 9(1): 62-69.

[9] Gaide O, Herrera F, Jeanneret Sozzi W et al. Comparison of ultra-high versus conventional dose rate radiotherapy in a patient with cutaneous lymphoma. Radiother Oncol. 2022; 174: 87-91.

[10] Favaudon V, Caplier L, Monceau V et al. Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice. Sci Transl Med. 2014; 6(245): 245ra293.

[11] Bourhis J, Sozzi WJ, Jorge PG et al. Treatment of a first patient with FLASH-radiotherapy. Radiother Oncol. 2019; 139: 18-22.

[12] Gonçalves Jorge P, Grilj V, Bourhis J et al. Technical note: Validation of an ultrahigh dose rate pulsed electron beam monitoring system using a current transformer for FLASH preclinical studies. Med Phys. 2022; 49(3): 1831-1838.

[13] Wootton LS, Meyer J, Kim E, Phillips M. Commissioning, clinical implementation, and performance of the Mobetron 2000 for intraoperative radiation therapy. J Appl Clin Med Phys. 2017; 18(1): 230-242.

[14] Moeckli R, Gonçalves Jorge P, Grilj V et al. Commissioning of an ultra-high dose rate pulsed electron beam medical LINAC for FLASH RT preclinical animal experiments and future clinical human protocols. Med Phys. 2021; 48(6): 3134-3142.

[15] Ma LJ, Mao RH, Lei HC et al. Transform routine medical accelerators to achieve Flash-RT and physical performance measurements. Chine J Radia Oncol. 2022; 31(11): 1022-1027.

[16] Lempart M, Blad B, Adrian G et al. Modifying a clinical linear accelerator for delivery of ultra-high dose rate irradiation. Radiother Oncol. 2019; 139: 40-45.

[17] No HJ, Wu YF, Dworkin ML et al. Clinical Linear Accelerator-Based Electron FLASH: Pathway for Practical Translation to FLASH Clinical Trials. Int J Radiat Oncol Biol Phys. 2023; 117(2): 482-492.

[18] Schüler E, Trovati S, King G et al. Experimental Platform for Ultra-high Dose Rate FLASH Irradiation of Small Animals Using a Clinical Linear Accelerator. Int J Radiat Oncol Biol Phys. 2017; 97(1): 195-203.

[19] Garty G, Obaid R, Deoli N et al. Ultra-high dose rate FLASH irradiator at the radiological research accelerator facility. Scientific Reports. 2022; 12(1): 22149.

[20] Whitmore L, Mackay RI, van Herk M, Jones JK, Jones RM: Focused VHEE (very high energy electron) beams and dose delivery for radiotherapy applications. Scientific Reports. 2021; 11(1): 14013.

[21] Ronga MG, Cavallone M, Patriarca A et al. Back to the Future: Very High-Energy Electrons (VHEEs) and Their Potential Application in Radiation Therapy. Cancers (Basel). 2021; 13(19).

[22] Subiel A, Moskvin V, Welsh GH et al. Dosimetry of very high energy electrons (VHEE) for radiotherapy applications: using radiochromic film measurements and Monte Carlo simulations. Phys Med Biol. 2014; 59(19): 5811-5829.

[23] Böhlen TT, Germond JF, Desorgher L et al. Very high-energy electron therapy as light-particle alternative to transmission proton FLASH therapy - An evaluation of dosimetric performances. Radiother Oncol. 2024; 194: 110177.

[24] Small KL, Henthorn NT, Angal-Kalinin D et al. Evaluating very high energy electron RBE from nanodosimetric pBR322 plasmid DNA damage. Sci Rep. 2021; 11(1): 3341.

[25] Siddique S, Ruda HE, Chow JCL. FLASH Radiotherapy and the Use of Radiation Dosimeters. Cancers (Basel). 2023; 15(15).

[26] McManus M, Romano F, Lee ND et al. The challenge of ionisation chamber dosimetry in ultra-short pulsed high dose-rate Very High Energy Electron beams. Scientific Reports. 2020; 10(1): 9089.

[27] Subiel A, Romano F: Recent developments in absolute dosimetry for FLASH radiotherapy. Br J Radiol. 2023; 96(1148): 20220560.

[28] Romano F, Bailat C, Jorge PG, Lerch MLF, Darafsheh A: Ultra-high dose rate dosimetry: Challenges and opportunities for FLASH radiation therapy. Med Phys. 2022; 49(7): 4912-4932.

[29] Marinelli M, Felici G, Galante F et al. Design, realization, and characterization of a novel diamond detector prototype for FLASH radiotherapy dosimetry. Med Phys. 2022; 49(3): 1902-1910.

[30] Zhou WY, Gong H, Qiu R et al. Feasibility of diamond detector on Flash radiation dosimetry online. Chine J Radio Med Prot. 2023; 43(9): 729-735.

[31] Alexander DA, Decker SM, Jermyn M et al. One Year of Clinic-Wide Cherenkov Imaging for Discovery of Quality Improvement Opportunities in Radiation Therapy. Pract Radiat Oncol. 2023; 13(1): 71-81.

[32] Held KD, McNamara AL, Daartz J, Bhagwat MS, Rothwell B, Schuemann J: Dose Rate Effects from the 1950s through to the Era of FLASH. Radiat Res. 2024; 202(2): 161-176.

[33] Montay-Gruel P, Markarian M, Allen BD et al. Ultra-High-Dose-Rate FLASH Irradiation Limits Reactive Gliosis in the Brain. Radiat Res. 2020; 194(6): 636-645.

[34] Mascia A, McCauley S, Speth J et al. Impact of Multiple Beams on the FLASH Effect in Soft Tissue and Skin in Mice. Int J Radiat Oncol Biol Phys. 2024; 118(1): 253-261.

[35] Vozenin MC, Hendry JH, Limoli CL. Biological Benefits of Ultra-high Dose Rate FLASH Radiotherapy: Sleeping Beauty Awoken. Clin Oncol (R Coll Radiol). 2019; 31(7): 407-415.

[36] Levy K, Natarajan S, Wang J et al. Abdominal FLASH irradiation reduces radiation-induced gastrointestinal toxicity for the treatment of ovarian cancer in mice. Sci Rep. 2020; 10(1): 21600.

[37] Chabi S, To THV, Leavitt R et al. Ultra-high-dose-rate FLASH and Conventional-Dose-Rate Irradiation Differentially Affect Human Acute Lymphoblastic Leukemia and Normal Hematopoiesis. Int J Radiat Oncol Biol Phys. 2021; 109(3): 819-829.

[38] El Khatib M, Van Slyke AL, Velalopoulou A et al. Ultrafast Tracking of Oxygen Dynamics During Proton FLASH. Int J Radiat Oncol Biol Phys. 2022; 113(3): 624-634.

[39] Kacem H, Psoroulas S, Boivin G et al. Comparing radiolytic production of H(2)O(2) and development of Zebrafish embryos after ultra high dose rate exposure with electron and transmission proton beams. Radiother Oncol. 2022; 175: 197-202.

[40] Shi X, Yang Y, Zhang W et al. FLASH X-ray spares intestinal crypts from pyroptosis initiated by cGAS-STING activation upon radioimmunotherapy. Proc Natl Acad Sci U S A. 2022; 119(43): e2208506119.

[41] Chow JCL, Ruda HE. Mechanisms of Action in FLASH Radiotherapy: A Comprehensive Review of Physicochemical and Biological Processes on Cancerous and Normal Cells. Cells. 2024; 13(10).

[42] Jin JY, Gu A, Wang W, Oleinick NL, Machtay M, Spring Kong FM. Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect? Radiother Oncol. 2020; 149: 55-62.

[43] Luo H, Sun Y, Wang L, Zhao R, James B: Cellular proteomic profiling of esophageal epithelial cells cultured under physioxia or normoxia reveals high correlation of radiation response. Radiation Medicine and Protection. 2023; 4(2): 86-92.

[44] Rakotomalala A, Escande A, Furlan A, Meignan S, Lartigau E: Hypoxia in Solid Tumors: How Low Oxygenation Impacts the “Six Rs” of Radiotherapy. Frontiers in endocrinology. 2021; 12: 742215.

[45] Cherbuin N, Ollivier J, Jorge PG et al. PO-1930 Plasmid DNA damages after FLASH vs conventional dose rate irradiations in various oxygen conditions. Radiotherapy and Oncology. 2021.

[46] Montay-Gruel P, Acharya MM, Gonçalves Jorge P et al. Hypofractionated FLASH-RT as an Effective Treatment against Glioblastoma that Reduces Neurocognitive Side Effects in Mice. Clin Cancer Res. 2021; 27(3): 775-784.

[47] Ruan JL, Lee C, Wouters S et al. Irradiation at Ultra-High (FLASH) Dose Rates Reduces Acute Normal Tissue Toxicity in the Mouse Gastrointestinal System. Int J Radiat Oncol Biol Phys. 2021; 111(5): 1250-1261.

[48] Abolfath R, Grosshans D, Mohan R: Oxygen depletion in FLASH ultra-high-dose-rate radiotherapy: A molecular dynamics simulation. Med Phys. 2020; 47(12): 6551-6561.

[49] Cao X, Zhang R, Esipova TV et al. Quantification of Oxygen Depletion During FLASH Irradiation In Vitro and In Vivo. Int J Radiat Oncol Biol Phys. 2021; 111(1): 240-248.

[50] Grilj V, Leavitt RJ, El Khatib M et al. In vivo measurements of change in tissue oxygen level during irradiation reveal novel dose rate dependence. Radiother Oncol. 2024; 201: 110539.

[51] Azzam EI, Jay-Gerin JP, Pain D: Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. Cancer Lett. 2012; 327(1-2): 48-60.

[52] Kacem H, Almeida A, Cherbuin N, Vozenin MC: Understanding the FLASH effect to unravel the potential of ultra-high dose rate irradiation. Int J Radiat Biol. 2022; 98(3): 506-516.

[53] Montay-Gruel P, Acharya MM, Petersson K et al. Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species. Proc Natl Acad Sci U S A. 2019; 116(22): 10943-10951.

[54] Bogaerts E, Macaeva E, Isebaert S, Haustermans K: Potential Molecular Mechanisms behind the Ultra-High Dose Rate “FLASH” Effect. Int J Mol Sci. 2022; 23(20).

[55] Guo Z, Buonanno M, Harken A, Zhou G, Hei TK: Mitochondrial Damage Response and Fate of Normal Cells Exposed to FLASH Irradiation with Protons. Radiat Res. 2022; 197(6): 569-582.

[56] Han J, Mei Z, Lu C et al. Ultra-High Dose Rate FLASH Irradiation Induced Radio-Resistance of Normal Fibroblast Cells Can Be Enhanced by Hypoxia and Mitochondrial Dysfunction Resulting From Loss of Cytochrome C. Front Cell Dev Biol. 2021; 9: 672929.

[57] Lv J, Sun J, Luo Y, et al. FLASH Irradiation Regulates IFN-β induction by mtDNA via Cytochrome c Leakage; 2024.

[58] Galts A, Hammi A: FLASH radiotherapy sparing effect on the circulating lymphocytes in pencil beam scanning proton therapy: impact of hypofractionation and dose rate. Phys Med Biol. 2024; 69(2).

[59] Almeida A, Godfroid C, Leavitt RJ et al. Antitumor Effect by Either FLASH or Conventional Dose Rate Irradiation Involves Equivalent Immune Responses. Int J Radiat Oncol Biol Phys. 2024; 118(4): 1110-1122.

[60] Cytlak UM, Dyer DP, Honeychurch J, Williams KJ, Travis MA, Illidge TM: Immunomodulation by radiotherapy in tumour control and normal tissue toxicity. Nat Rev Immunol. 2022; 22(2): 124-138.

[61] Rohrer Bley C, Wolf F, Gonçalves Jorge P et al. Dose- and Volume-Limiting Late Toxicity of FLASH Radiotherapy in Cats with Squamous Cell Carcinoma of the Nasal Planum and in Mini Pigs. Clin Cancer Res. 2022; 28(17): 3814-3823.

[62] Vozenin MC, De Fornel P, Petersson K et al. The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients. Clin Cancer Res. 2019; 25(1): 35-42.

[63] Durkan JP, Henderson MA: Ethics of clinical trials. Anaesthesia & Intensive Care Medicine. 2023; 24(11): 725-728.

[64] Jain S: Radiation in medical practice & health effects of radiation: Rationale, risks, and rewards. Journal of family medicine and primary care. 2021; 10(4): 1520-1524.

[65] Majeed H, Gupta V: Adverse Effects of Radiation Therapy. In: StatPearls. edn. Treasure Island (FL) ineligible companies. Disclosure: Vikas Gupta declares no relevant financial relationships with ineligible companies. StatPearls Publishing Copyright © 2024, StatPearls Publishing LLC. 2024.

[66] Böhlen TT, Germond JF, Bourhis J et al. Normal Tissue Sparing by FLASH as a Function of Single-Fraction Dose: A Quantitative Analysis. Int J Radiat Oncol Biol Phys. 2022; 114(5): 1032-1044.

[67] Maity A, Koumenis C: Shining a FLASHlight on Ultrahigh Dose-Rate Radiation and Possible Late Toxicity. Clin Cancer Res. 2022; 28(17): 3636-3638.

[68] Selvaraj B, Zhao X, Lin H et al. Bragg Peak FLASH Technique with Clinical SBRT Regimen Delivers High-Conformity FLASH Radiotherapy for Spinal Cancers. International Journal of Radiation Oncology*Biology*Physics. 2024; 120(2, Supplement): e186.

[69] Hanley J, Dresser S, Simon W et al. AAPM Task Group 198 Report: An implementation guide for TG 142 quality assurance of medical accelerators. Med Phys. 2021; 48(10): e830-e885.

[70] Zou W, Zhang R, Schüler E et al. Framework for Quality Assurance of Ultrahigh Dose Rate Clinical Trials Investigating FLASH Effects and Current Technology Gaps. Int J Radiat Oncol Biol Phys. 2023; 116(5): 1202-1217.

RIGHTS & PERMISSIONS

2025 The Author(s). Precision Radiation Oncology published by John Wiley & Sons Australia, Ltd on behalf of Shandong Cancer Hospital & Institute.